H

Hyundai Bioscience Co Ltd
KOSDAQ:048410

Watchlist Manager
Hyundai Bioscience Co Ltd
KOSDAQ:048410
Watchlist
Price: 14 670 KRW 1.24% Market Closed
Market Cap: 584.1B KRW
Have any thoughts about
Hyundai Bioscience Co Ltd?
Write Note

Net Margin
Hyundai Bioscience Co Ltd

-71.1%
Current
-168%
Average
3.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-71.1%
=
Net Income
-6.6B
/
Revenue
9.2B

Net Margin Across Competitors

Country KR
Market Cap 584.1B KRW
Net Margin
-71%
Country FR
Market Cap 177.9B EUR
Net Margin
15%
Country UK
Market Cap 118B GBP
Net Margin
11%
Country IN
Market Cap 5.8T INR
Net Margin
17%
Country UK
Market Cap 34.5B GBP
Net Margin
11%
Country DE
Market Cap 27.8B EUR
Net Margin
8%
Country US
Market Cap 27.2B USD
Net Margin
1%
Country JP
Market Cap 3T JPY
Net Margin
5%
Country IN
Market Cap 1.3T INR
Net Margin
-3%
Country IN
Market Cap 935.5B INR
Net Margin
14%
Country US
Market Cap 10.1B USD
Net Margin
12%
No Stocks Found

Hyundai Bioscience Co Ltd
Glance View

Market Cap
584.1B KRW
Industry
Consumer products

HYUNDAI BIOSCIENCE Co., Ltd. engages in the manufacture and sale of bio-cosmetics and hair tonics. The company is headquartered in Gimcheon, Gyeongsangbuk-Do. The company went IPO on 2002-08-08. The company develops functional daily necessities such as shampoos, mask packs, creams, and tumor-targeted drug. The firm also sells liquid crystal display (LCD) monitors and digital signage display products. The firm distributes its products in domestic market, as well as to the overseas markets, including Europe, America and Japan.

Intrinsic Value
501.94 KRW
Overvaluation 97%
Intrinsic Value
Price
H

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-71.1%
=
Net Income
-6.6B
/
Revenue
9.2B
What is the Net Margin of Hyundai Bioscience Co Ltd?

Based on Hyundai Bioscience Co Ltd's most recent financial statements, the company has Net Margin of -71.1%.